Filling a gap that pharma fails to fund, a new initiative will develop vaccines to prevent outbreaks of emerging viruses.
The most fascinating and important news in technology and innovation delivered straight to your inbox, every day.
Her death is a reminder that antibiotic-resistant bacteria are getting worse, even as they garner little attention.
For the first time, funding from the U.S. government may be spent on man-made approaches to ease climate change.
Experts warn that a potential IVF breakthrough could have unintended social consequences.
Changing economic realities mean that America is already reducing its emissions, but the president says more action is needed to accelerate the process.
The technique could be faster and more versatile than developing genetically modified crops from scratch.
Grail, a company that aims to use a blood test to spot cancer, has announced a massive round of funding for its experimental approach.
Researchers have tested a modified malaria parasite in humans that has been shown to be safe and to trigger an immune response.
But most impressive of all, it’s running without subsidies.